Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 52 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
511 17.5 months Advanced NSCLC 3 Biologic therapy
Massachusetts General Hospital Cancer Center United States 5/2008
Treatment Details: Patients: This phase II study involved 31 patients with advanced non-small-cell lung cancer. These patients also had a mutation in a gene called EGFR. The median age was 62, ranging from
 
512 17.5 months Stage IIIA-N2 NSCLC 4 Chemotherapy
Radiation
Surgery
University Hospital Ghent Belgium 3/2007
Treatment Details: Patients: This study involved 579 patients with stage IIIA-N2 non-small cell lung cancer. Of these, 74% were men and 26% were women. The median age was 61 years. Treatment: All patien
 
513 17.4 months Metastatic prostate cancer 4 Biologic therapy
Institut Paoli-Calmettes France 9/2008
Treatment Details: Patients: This phase II study involved 30 men with metastatic prostate cancer. The median age was 69, ranging from 51 to 77 years old. Most (77%) had previously been treated with chemothe
 
514 17.4 months Advanced colorectal cancer 5 Chemotherapy
Radboud University Nijmegen Medical Centre Netherlands 7/2007
Treatment Details: Patients: This study involved 803 patients with advanced colorectal cancer. Twenty-two percent were older than 70 years and the median age was 63, ranging from 27 to 84. Most (63%) were m
 
515 17.4 months Stage IIIIB and IV NSCLC 2 Biologic therapy
Chemotherapy
Cross Cancer Institute Canada 9/2005
Treatment Details: Patients: This Phase II study involved 171 patients with advanced non-small-cell lung cancer who were randomly assigned into two groups. Group A had 88 patients (52 men, 36 women) with a me
 
516 17.4 months Stage IIIA NSCLC 5 Chemotherapy
Radiation
University of Rochester Medical Center United States 10/2002
Treatment Details: Patients & Treatment: This Phase III study involved a total of 73 patients with stage IIIA non-small-cell lung cancer. Patients were divided into 5 groups. Group 1 (7 patients) received th
 
517 17.4 months Metastatic colorectal cancer 5 Chemotherapy
University of Texas Medical Branch United States 11/2004
Treatment Details: Patients: This Phase II study involved 28 patients with advanced colorectal cancer with distant metastases. Treatment: Treatment consisted of three drugs 5-FU (adrucil), leucovorin, and
 
518 17.4 months Metastatic colorectal cancer 5 Chemotherapy
University of Texas Medical Branch United States 11/2004
Treatment Details: Patients: This Phase II study involved 28 patients with advanced colorectal cancer with distant metastases. Treatment: Treatment consisted of three drugs 5-FU (adrucil), leucovorin, and
 
519 17.4 months Metastatic, Castration-Resistant Prostate Cancer 5 Hormone
Medizinische Hochschule Hannover Germany 1/2015
Treatment Details: Patients: This phase 3 study involved 263 metastatic castration-resistant prostate cancer patients who had received prior docetaxel-based chemotherapy. The average patient age was 69.2 yea
 
520 17.4 months Advanced urothelial carcinoma 4 Chemotherapy
University of Michigan United States 5/2014
Treatment Details: Patients: This phase 2 study involved advanced urothelial carcinoma patients who were divided into two separate treatment groups. Group A consisted of 28 patients with a median age of 65.8
 
Page 52 of 187  | Previous Page  | Next Page